Malaria vaccine trial shows the potentiating power of incremental progress

Brandon Wilder

doi:10.1016/j.medj.2021.05.004

Malaria vaccine trial shows the potentiating power of incremental progress

Brandon Wilder

Vaccine and Gene Therapy Institute

Research output: Contribution to journal › Article › peer-review

Abstract

The complexity of malaria has precluded many “slam dunk” attempts at a vaccine. In this issue, Minassian et al.¹ present efficacy trial results that demonstrate progress for a much-anticipated malaria vaccine candidate and pave the way to future iterations by validating a comprehensive vaccine development framework.

Original language	English (US)
Pages (from-to)	635-636
Number of pages	2
Journal	Med
Volume	2
Issue number	6
DOIs	https://doi.org/10.1016/j.medj.2021.05.004
State	Published - Jun 11 2021

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/j.medj.2021.05.004

Cite this

@article{0974c89698844d9896acc5d5d96bb7c0,

title = "Malaria vaccine trial shows the potentiating power of incremental progress",

abstract = "The complexity of malaria has precluded many “slam dunk” attempts at a vaccine. In this issue, Minassian et al.1 present efficacy trial results that demonstrate progress for a much-anticipated malaria vaccine candidate and pave the way to future iterations by validating a comprehensive vaccine development framework.",

author = "Brandon Wilder",

note = "Funding Information: This work is supported by the Bill and Melinda Gates Foundation (INV-005170), Novartis Institutes for Biomedical Research, and the National Institute of Allergy and Infectious Diseases (R01 AI123182) Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = jun,

day = "11",

doi = "10.1016/j.medj.2021.05.004",

language = "English (US)",

volume = "2",

pages = "635--636",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - Malaria vaccine trial shows the potentiating power of incremental progress

AU - Wilder, Brandon

N1 - Funding Information: This work is supported by the Bill and Melinda Gates Foundation (INV-005170), Novartis Institutes for Biomedical Research, and the National Institute of Allergy and Infectious Diseases (R01 AI123182) Publisher Copyright: © 2021 Elsevier Inc.

PY - 2021/6/11

Y1 - 2021/6/11

N2 - The complexity of malaria has precluded many “slam dunk” attempts at a vaccine. In this issue, Minassian et al.1 present efficacy trial results that demonstrate progress for a much-anticipated malaria vaccine candidate and pave the way to future iterations by validating a comprehensive vaccine development framework.

AB - The complexity of malaria has precluded many “slam dunk” attempts at a vaccine. In this issue, Minassian et al.1 present efficacy trial results that demonstrate progress for a much-anticipated malaria vaccine candidate and pave the way to future iterations by validating a comprehensive vaccine development framework.

UR - http://www.scopus.com/inward/record.url?scp=85122979568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122979568&partnerID=8YFLogxK

U2 - 10.1016/j.medj.2021.05.004

DO - 10.1016/j.medj.2021.05.004

M3 - Article

C2 - 35590135

AN - SCOPUS:85122979568

SN - 2666-6359

VL - 2

SP - 635

EP - 636

JO - Med

JF - Med

IS - 6

ER -

Malaria vaccine trial shows the potentiating power of incremental progress

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this